← Back to headlines
Taysha Gene Therapies Details REVEAL Program Timeline
Taysha Gene Therapies has outlined its REVEAL program's development schedule, anticipating a 6-month interim analysis and FDA feedback in the first half of 2027, with PPQ completion targeted for the fourth quarter of 2026.
12 Aug, 01:38 — 12 Aug, 01:38
Sources
Showing 1 of 1 sources
